Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research...
-
Upload
hillary-karin-bridges -
Category
Documents
-
view
220 -
download
1
Transcript of Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research...
![Page 1: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/1.jpg)
Epi 202: Designing Clinical Research
Introduction to the Course, Clinical Research and Research Questions
Thomas B. Newman, MD, MPH
Professor of Epidemiology & Biostatistics and Pediatrics, UCSF
July 31, 2012
![Page 2: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/2.jpg)
Outline About this course Anatomy and Physiology of
Research Research questions Examples: jaundice in newborns
![Page 3: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/3.jpg)
About This Course Began > 30 years ago Also known as the
"Hulley Course" Steve was the leader for
the text (DCR) and designed the course, homework, and instructions to section leaders
Steve Hulley
![Page 4: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/4.jpg)
About This Course Michael Kohn
–Co-director, 2004 – 2011
Joel Simon –Section leader,
1991– –Course co-
director, 2012
![Page 5: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/5.jpg)
Website Google “Epi 202” or find
from TICR home page Course roster, schedule,
rooms, readings, PowerPoint files (when available)
Links to recordings of lectures– This class– Epi 150.03/CTSI site
Forum
![Page 6: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/6.jpg)
About the Reading -1 DCR-3 includes exercises
and answers at the end of the book– We recommend jotting
down answers before reading ours
– Can discuss in section but usually won’ t be turned in
Let us know your suggestions for improving the book! (Now working on DCR-4!)
![Page 7: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/7.jpg)
About the Reading -2 Recommended reading this
week (Saha et al. Survival guide…) on the Epi 202 website
Evidence-Based Diagnosis (EBD) text also recommended; you’ll need it for Epi 204
![Page 8: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/8.jpg)
Course Objectives1. Learn about how to design and
do clinical research
2. Produce a protocol for a study
3. Help others in the workshop
4. Provide feedback on the workshop
5. Have a multiplier effect
![Page 9: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/9.jpg)
Course Ingredients
July 31- Lectures (9:10 – 10:00)
Sept 11 * Selected issues from DCR 3 text and examples
Sections (10:10 – 12:00)
* Protocol components
* More issues from the text
* Helping and getting to know your classmates
Sept 18 5-page protocols due
Oct 2, 9, tba Protocol review sessions (not Masters or ATCR Students)
* In pairs and trios, new faculty
Prefer 9:00 start?
![Page 10: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/10.jpg)
Grades, Attendance, Interruptions, etc.
5-page protocol must be turned in to pass– Protocol review sessions encouraged but not req’d
To get an A, in addition:– No unexcused absences– No more than 1 missing or late HW– Help your colleagues with their protocols
Class time is sacred– Do not answer cell phones or pages except
emergencies– If clinical responsibilities will interfere, please
arrange coverage or take this class another time
![Page 11: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/11.jpg)
Faculty for sectionsName Field
Naomi Bardach General PediatricsHal Barron Cardiology
Michael Cabana General PediatricsCarlos Iribarren EpidemiologyBruce Gaynor Ophthalmology
Hannah Glass Child Neurology
Mary Haan EpidemiologyAnthony Kim* Neurology
Conan MacDougal Clinical PharmacyJoel Simon General Medicine
John Takayama* General Pediatrics
Jess Waldura Family MedicineJanet Wojcicki Pediatrics/GI
*E-sections
![Page 12: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/12.jpg)
Course CoordinatorOlivia De Leon
514-8231 (tel)
514-8150 (fax)
(Please let her know if your email address changes by sending her an email from the new address)
Olivia De Leon
![Page 13: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/13.jpg)
Questions?
USE MICROPHONE OR REPEAT
![Page 14: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/14.jpg)
Anatomy of research: What it’s made of Research question, significance Study design Study subjects and how they will be sampled Variables and how they will be measured
– Predictor – Outcome
Analysis plan, sample size calculation Implementation, data management, quality
control
![Page 15: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/15.jpg)
Required Viewing for Next Week
![Page 16: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/16.jpg)
Research Questions for Epi 202
Not the best choice for this course– Animals, molecules without humans– Data syntheses, e.g. decision analysis,
cost-effectiveness analysis, meta-analysis
– Qualitative research
Ideal– A new observational study or clinical trial
involving humans that you could do (or at least start) this year
![Page 17: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/17.jpg)
What if I am doing a secondary data analysis? You can:
Use it for your DCR project, rethinking decisions that were already made and getting thoughts and suggestions for colleagues
Design a new study you may not be planning to do
![Page 18: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/18.jpg)
Physiology of research: How it works
Using measurements in a sample to draw inferences about phenomena in a population
![Page 19: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/19.jpg)
DCR Figure 1.3
![Page 20: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/20.jpg)
DCR Figure 1.4
![Page 21: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/21.jpg)
DCR Figure 1.5
![Page 22: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/22.jpg)
Questions?
USE MICROPHONE OR REPEAT
![Page 23: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/23.jpg)
Do I really have to do all of those laboratory tests before I can start phototherapy in jaundiced babies?
Newman research question #1
![Page 24: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/24.jpg)
Background about neonatal jaundice Bilirubin: Yellow
breakdown product of heme (from red blood cells)
Jaundice: Yellow color of whites of eyes and skin due to high bilirubin. Usually indicates liver or blood disease, but generally is normal in newborns
![Page 25: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/25.jpg)
Background to Question #1, cont’d
Phototherapy: shining light on the baby’s skin helps lower bilirubin levels
Very high bilirubin levels (“hyperbilirubinemia”) can cause kernicterus (brain damage)– More common in
developing countries
![Page 26: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/26.jpg)
Do I really have to do all of those laboratory tests before I can start phototherapy in jaundiced babies?
My first grant: Laboratory Evaluation of Jaundice in Newborns (“LEJN”)
Newman research question #1
![Page 27: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/27.jpg)
Digression: the importance of a good acronym Fun initial way to engage collaborators Gives your study credibility and life Useful for naming files and directories Worth the effort!
![Page 28: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/28.jpg)
The importance of a good acronym: Examples Multiple Risk Factor Intervention Trial = MRFIT Late Impact of Getting
Hyperbilirubinemia or photoTherapy = LIGHT
![Page 29: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/29.jpg)
The importance of a good acronym: Examples A study of the cost effectiveness of
differerent protocols for treating gestational diabetes (James G. Kahn, MD, MPH)
Gestational Diabetes Formulas for Cost-Effectiveness
GeDi FORCE
![Page 30: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/30.jpg)
Background to Question #1, cont’d A complete "hyperbilirubinemia work-
up" used to be recommended for significant newborn jaundice:– Total and direct bilirubin– Direct and indirect Coombs’ tests– Complete Blood Count– Blood smear for red cell morphology– Reticulocyte count– Urine reducing substance
![Page 31: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/31.jpg)
Background to Question #1, cont’d In TN’s experience reference ranges
were poorly defined and results rarely if ever affected management
As a pediatric resident TN did not like having to get out of bed to draw blood for these tests before being allowed to start phototherapy
![Page 32: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/32.jpg)
TN concerned about costs
![Page 33: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/33.jpg)
More refined research question #1(i.e., what we really want to know)
Do the expected health benefits of the recommended tests justify their costs?
Subjects: Jaundiced newborns (candidates for phototherapy)
Predictor variable: obtaining the tests Outcome variable: measurements of
health and costs
![Page 34: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/34.jpg)
Laboratory Evaluation of Jaundice in Newborns (LEJN) study questions
(i.e., questions our study can answer) How often are each of these tests done in
newborns at UCSF and Stanford? How often are they abnormal? When they are abnormal what diagnoses
are made as a result of the test? How often is treatment altered? Diagnostic yield study (Chapter 12);
primarily descriptive
![Page 35: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/35.jpg)
Compromises Just 2 S.F. Bay Area teaching hospitals Surrogate outcome:
– Discharge diagnosis of a significant disease– Diagnosed after an abnormal jaundice work-up
Retrospective study– Limited to those in whom MD ordered the tests,
rather than those with a certain level of jaundice or meeting other inclusion criteria
– No control over laboratory methods for doing the tests
![Page 36: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/36.jpg)
Is RQ /Study Plan FINER?
Feasible
Interesting
Novel
Ethical
Relevant
![Page 37: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/37.jpg)
Can you put your FINGER on a good research question?
Feasible
Interesting
Novel
Good for your career
Ethical
Relevant
![Page 38: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/38.jpg)
Good for your career
Try to identify a research question that will allow you to– Learn more about an area of potential
long-term interest– Acquire new skills you could use on other
projects– Work with people and/or organizations with
whom you want to develop a long term relationship
– Build on the project for future work
![Page 39: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/39.jpg)
LEJN: Direct Bilirubin Results -1 Test ordered 15 times as often per infant at
UCSF as at Stanford Results more than twice as high
AJDC 1991;145:1305-1309
Total N births
•Stanford: 5,185
•UCSF: 5,778
mg/dL
1 2 3 4
![Page 40: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/40.jpg)
LEJN Results: Direct Bilirubin Results -2AJDC 1991;145:1305-09
Spontaneous resolution in all 4 infants
![Page 41: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/41.jpg)
LEJN Conclusions
“Because of their low yield and poor specificity, direct bilirubin tests are seldom helpful in evaluating jaundice in term newborns.”*
Current guidelines: check direct bilirubin for unexplained rapid rise, babies needing phototherapy, persistence > 3 wks or sick baby
*AJDC 1991;145:1305-1309
![Page 42: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/42.jpg)
Background to TN RQ #2 It is known that very high (>
~30 mg/dL) bilirubin levels can cause horrible brain damage (kernicterus)
Unclear how often kernicterus or more subtle abnormalities occur at lower bilirubin levels
Concern about this possibility leads to more treatment
Bilirubin levels 25 mg/dL are rare (~1/700)
![Page 43: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/43.jpg)
Background to TN RQ#2, cont’d
During the 1990s hospital stays for newborns shortened dramatically
There were reports of increases in kernicterus and severe dehydration
We had already identified cases of bilirubin 25 mg/dL and dehydation from previous nested case-control studies
RQ: What are the effects of neonatal bilirubin levels 25 mg/dL and dehydration on neurodevelopmental outcomes?
![Page 44: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/44.jpg)
Acronyms Sequelae of Hyperbilirubinemia and
Dehydration in Infants “SHADI” Jaundice and Infant FEEding Study JIFee
![Page 45: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/45.jpg)
Study Design
Triple Cohort Study– Hyperbilirubinemia group (TSB 25 mg/dL
at < 30 days)– Dehydration group (readmitted for
dehydration + either 12% weight loss or Na >= 150 mEq/L)
– Randomly selected comparison group Outcomes: blinded full neurodevelopmental
evaluations at age ~5 by psychologists and child neurologists
![Page 46: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/46.jpg)
Compromises and challenge Difficulty recruiting “controls”
– Full exams on 82/140 (59%) hyperbili cases vs 168/419 (40%) of controls
Outcomes– Interobserver variability, subjectivity in
examinations– Measurements at age 5 years may miss
relevant school problems later– 5-year-olds get tired and have bad days– No hearing tests
![Page 47: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/47.jpg)
Results: continuous variables
Control (N=168)
Hyperbili
(N=82)Adjusted
difference PWPPSI-R
Verbal IQ 101.1 103.52.5 (-1.1 to
6.1) 0.18
Performance IQ 106.0 107.00.5 (−2.9 to
4.0) 0.29
Full Scale IQ 104.0 105.91.4 (−2.1 to
5.0) 0.42 VMI-4
VMI 102.1 103.30.6 (−2.8 to
3.9) 0.74Visual
perception 105.9 107.51.2 (−3.5 to
6.0) 0.6Motor
coordination 100.4 101.3−1.3 (−5.6 to
2.9) 0.54
![Page 48: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/48.jpg)
Results: Adjusted OR and 95% CI for Dichotomized Outcomes
![Page 49: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/49.jpg)
PublicationPublication
Submitted to JAMA Rejected Submitted to NEJM Rejected
– Lower participation rate in controls (40% vs 59%)
– Questionable importance
![Page 50: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/50.jpg)
Decision appealed!
Even if all unexamined controls normal, no change in results
Google search Timely e-mail
![Page 51: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/51.jpg)
Google search results "Jaundice baby”
– Second hit: www.kernicterus.org “Kernicterus”
– First hit: PICK website• Bilirubin as a neurotoxin• Treatment advocated at lower levels than those
recommended by the AAP
![Page 52: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/52.jpg)
E-mail from a parent -1
To: <[email protected]>
Subject: my hyperbili son
Date: Thu, 11 Aug 2005
Dear Dr Newman,
I would like your input as to the prognosis with my son. He had a neonatal jaundice that was horribly mismanaged and I am now a hysterical mom....
My son was born [Wednesday] 4/13/2005 at 10am...On Sat night we had him tested, at 8pm TBR was 24, Coombs test positive. He was admitted under double lights and his TBR was 16 on Sun morn...
![Page 53: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/53.jpg)
E-mail from a parent -2
He was breast fed throughout and had a strong suck.
He is now 4 months old and milestones seem within developmental norms. Hearing seems ok.
I am sleepless, hysterical and depressed. How concerned for the future do I have to be?
Please could you get back to me asap.
Thanking you, Tracey P
![Page 54: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/54.jpg)
![Page 55: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/55.jpg)
Today in section: one sentence describing anatomy of your study
Design Variables
– Predictor– Outcome
Subjects
![Page 56: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/56.jpg)
Questions and comments
![Page 57: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/57.jpg)
Extra slides
![Page 58: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/58.jpg)
Outcome Variables
Standard neurological examination by child neurologist*
IQ (WPPSI-R) and Visual-Motor Integration test (VMI) by psychologist*
Motor Performance Checklist (10 items like jumping, throwing, catching, putting beans in a bottle) by research associate*
Child Behavior Checklist (CBC-L) and Parent Evaluation of Developmental Status (PEDS) by parents
*Blinded to study group
![Page 59: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/59.jpg)
Example
This is a randomized double-blind trial to see whether low doses of oral diphenydramine reduce self-reported severity of motion sickness among elderly passengers on a cruise ship.
![Page 60: Epi 202: Designing Clinical Research Introduction to the Course, Clinical Research and Research Questions Thomas B. Newman, MD, MPH Professor of Epidemiology.](https://reader035.fdocuments.us/reader035/viewer/2022062314/56649e165503460f94b01213/html5/thumbnails/60.jpg)
Example
This is a prospective cohort study to estimate the effects of various medical treatments for osteoarthritis on the risk of intensive care unit admission for H1N1 influenza among members of the Northern California Kaiser Permanente Medical Care Program